Association of BRCA Mutations and BRCAness Status With Anticancer Drug Sensitivities in Triple-Negative Breast Cancer Cell Lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of BRCA Mutations and BRCAness Status With Anticancer Drug Sensitivities in Triple-Negative Breast Cancer Cell Lines

Published:2020-06 Issue: Volume:250 Page:200-208
ISSN:0022-4804
Container-title:Journal of Surgical Research
language:en
Short-container-title:Journal of Surgical Research

Author:

Teraoka Saeko,Muguruma Masako,Takano Naoharu^ORCID,Miyahara Kana,Kawate Takahiko,Kaise Hiroshi,Yamada Kimito,Miyazawa Keisuke^ORCID,Ishikawa Takashi

Publisher

Elsevier BV

Subject

Surgery

Reference34 articles.

1. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry;Bauer;Cancer,2007

2. Understanding the biology of triple-negative breast cancer;Criscitiello;Ann Oncol,2012

3. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin Cancer Res,2007

4. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc Natl Acad Sci U S A,2003

5. BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling;Sung;Oncogene,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of homologous recombination gene activity in breast tumor cells in an <i>in vitro</i> model;Advances in Molecular Oncology;2024-06-28

2. Case report: Emerging BRCA mutation confers benefit from olaparib after chemotherapy intolerance in advanced triple‐negative breast cancer;Clinical Case Reports;2024-04

3. Downregulation of TAB182 promotes cancer stem-like cell properties and therapeutic resistance in triple-negative breast cancer cells;BMC Cancer;2023-11-13

4. Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted;International Journal of Molecular Sciences;2022-06-29

5. Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress;Expert Opinion on Therapeutic Targets;2022-06-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3